LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.86 | 21.74 | 2593 | 1887 | 1.3741 | 1.1012 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.86 | 21.74 | 1855 | 1887 | 0.9830 | 0.9947 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.86 | 21.74 | 2081 | 1887 | 1.1028 | 1.0306 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.83 | 21.74 | 14 | 2110 | 0.0066 | -0.0645 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.83 | 21.74 | 2873 | 2110 | 1.3616 | 1.0957 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.83 | 21.74 | 1999 | 2110 | 0.9474 | 0.9837 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.83 | 21.74 | 2291 | 2110 | 1.0858 | 1.0251 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.80 | 21.74 | 30 | 2381 | 0.0126 | 0.0487 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.80 | 21.74 | 3182 | 2381 | 1.3361 | 1.0874 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.80 | 21.74 | 2362 | 2381 | 0.9918 | 0.9976 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.80 | 21.74 | 2507 | 2381 | 1.0527 | 1.0152 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 35.77 | 21.74 | 27 | 2602 | 0.0104 | 0.0319 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 35.77 | 21.74 | 3441 | 2602 | 1.3220 | 1.0825 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 35.77 | 21.74 | 2487 | 2602 | 0.9555 | 0.9869 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 35.77 | 21.74 | 2723 | 2602 | 1.0462 | 1.0131 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 37.74 | 21.74 | 24 | 2828 | 0.0085 | 0.0142 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 37.74 | 21.74 | 3717 | 2828 | 1.3142 | 1.0793 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 37.74 | 21.74 | 2700 | 2828 | 0.9546 | 0.9868 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 37.74 | 21.74 | 2951 | 2828 | 1.0433 | 1.0121 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 39.71 | 21.74 | 33 | 3084 | 0.0107 | 0.0601 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 39.71 | 21.74 | 4068 | 3084 | 1.3190 | 1.0790 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 39.71 | 21.74 | 2884 | 3084 | 0.9351 | 0.9813 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 39.71 | 21.74 | 3161 | 3084 | 1.0249 | 1.0069 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.68 | 21.74 | 55 | 3418 | 0.0161 | 0.1357 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.68 | 21.74 | 4451 | 3418 | 1.3019 | 1.0736 | MN20160310_N01 | I15 |